Compare DHIL & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DHIL | TOI |
|---|---|---|
| Founded | 1990 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medical/Nursing Services |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 319.2M | 327.6M |
| IPO Year | 1995 | N/A |
| Metric | DHIL | TOI |
|---|---|---|
| Price | $170.22 | $3.07 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 29.1K | ★ 1.9M |
| Earning Date | 02-25-2026 | 11-13-2025 |
| Dividend Yield | ★ 3.53% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 17.21 | N/A |
| Revenue | $149,665,296.00 | ★ $461,039,000.00 |
| Revenue This Year | N/A | $28.51 |
| Revenue Next Year | N/A | $23.54 |
| P/E Ratio | $9.89 | ★ N/A |
| Revenue Growth | 2.65 | ★ 21.67 |
| 52 Week Low | $114.11 | $0.60 |
| 52 Week High | $171.43 | $4.88 |
| Indicator | DHIL | TOI |
|---|---|---|
| Relative Strength Index (RSI) | 74.30 | 37.12 |
| Support Level | $170.02 | $3.30 |
| Resistance Level | $170.90 | $3.68 |
| Average True Range (ATR) | 0.74 | 0.28 |
| MACD | -1.38 | -0.08 |
| Stochastic Oscillator | 59.70 | 2.04 |
Diamond Hill Investment Group Inc sponsors, markets, and provides investment advisory and related services to various U.S. and foreign clients including mutual funds, separate accounts, and private investment funds. The company's objective is to fulfill a fiduciary duty to clients and secondary objectives to achieve an adequate long-term return for shareholders. The company generates its revenue from Investment advisory and fund administration fees.
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Majority of revenue is from patients services.